Abstract
The transcription factor Nrf2 (nuclear factor-erythroid 2 p45-related factor 2) play a crucial role in cellular redox and metabolic system. Activation of Nrf2 may be an effective therapeutic approach for neuroinflammatory disorders, through activation of antioxidant defences system, lower the inflammation, line up the mitochondrial function, and balancing of protein homeostasis. Various recent studies revealed that many of active substance obtained from plants have been found to activate the Nrf2 and to exert neuroprotective effects in various experimental models, raising the possibility that activation of Nrf2 may be an effective therapeutic approaches for neuroinflammatory disorders. The objective of this review was to evaluate the neuroprotective property of natural substance against neuroinflammatory disorders by reviewing the studies done till today. The outcomes of various in vitro and in vivo examinations have shown that natural compounds producing neuroprotective effects in neuronal system via activation of Nrf2. Herein, we also reviewed the studies to understand the role of Nrf2 for curing CNS disorders. Here we can conclude, herbal/natural moieties having potency to fight and prevent from neuroinflammatory disorders due to their abilities to activate Nrf2 pathway.
Keywords: Neuroinflammatory disorders, Neuroprotective effects, Natural compounds, Nrf2 pathway
Neuroinflammatory disorders, Neuroprotective effects, Natural compounds, Nrf2 pathway
1. Introduction
Neuroinflammation is nervous system inflammation that is prevalent in many neurodegenerative disorders such as Alzheimer's disease, Parkinson 's disease, Huntington 's disease, Amyotrophic lateral sclerosis (ALS) etc., characterised by microglia activation, inflammatory mediator release and reactive oxygen species (ROS) generation [1]. Studies have shown that neuroinflammation plays a crucial role in neurodegenerative disease growth. In several neurodegenerative diseases, neuroinflammation targeting is important because it aims to speed up interpretation of the immune process involved in neurodegenerative diseases [2]. Risk factors for neuroinflammation formation are distinct and are full responses that contribute to vascular compromise, oxidative stress and eventually lead to further formation of neurodegenerative diseases contributing to brain injury. The role of nuclear factor Erythroid 2-related factor 2 (Nrf2) is altered in many neurodegenerative diseases [3, 4].
Current studies have shown that there are several compounds isolated from natural plants that can delay neuronal damage and degenerative progression by inhibition of free radical generation and inflammation by activation of Nrf2, so they have attracted considerable attention as pharmacological treatments targeting neurodegenerative disorders [5]. Herbs or natural compounds have been known to control neurodegenerative diseases associated with neuroinflammation through antioxidant and anti-inflammatory activity [6]. Numerous natural substances are currently able to suppress neuroinflammation through the Nrf2-Responsive Antioxidant Element (ARE) pathway [7]. Many researchers are therefore focused on the pharmacological activation of Nrf2 in order to ameliorate neurodegenerative diseases. A number of studies have indicated that natural plants and their active components can counteract the progression of neurodegenerative diseases by activating Nrf2 [8]. Nrf2 is a transcription factor that controls antioxidant enzymes that protects against cellular system damage due to free radicle overproduction and is derived from Nuclear Factor. The gene Erythroid 2 Like 2 (NFE2L2) belongs to the family cap'n' transcription factor family [9]. Nrf2 exists in the cytoplasm with an inhibitory Nrf2 kelch protein such as ECH-associated protein1 (keap1) in the resting state. The levels of Nrf2 and its activation were basically regulated by keap1. At the level of free radicles, keap1 releases Nrf2 by altering main keap1 cysteine residues, facilitating the dissociation of the inhibitory complex and inducing its nuclear translocation sequentially [10]. The two pathways involved in Nrf2 activation are keap1 confirmation modification and Nrf2 phosphorylation. Nrf2 accumulates gene-dependent expression in the nucleus regulated by the basal antioxidant response factor and maintains cellular homeostasis. During the expression of Nrf2 target genes such as superoxide dismutase (SOD), heme oxygenase-1 (HO-1), glutathione (GSH), catalase (CAT), Uridine 5′-diphospho-glucuronosyltransferase (UDP-glucosyltransferase), Nrf2 forms a heterodimer in the nucleus with its partner musculoaponeurosis fibromatosis (sMaf) binding to ARE [9]. This is the Nrf2 conical pathway. Alternatively, non-conical mechanisms can disturb the interaction of keap1 and Nrf2 [11,12]. Figure 1 demonstrating the basic physiology of Nrf2 activation in both normal and stress conditions.
Figure 1.
Physiology of Nrf2 activation in both normal and stress conditions. In normal conditions, Nrf2 is associated with Keap1 by its two motifs (ETGE and DLG) that leads to CUL3-mediated ubiquitination followed by proteasome degradation. In oxidative stress, Nrf2 dissociates from Keap1, translocates to the nucleus and activates the ARE-gene system. KEAP1 = Kelch-like ECH-associated protein 1, CUL3 = Cullin 3, DLG = DLG motifs, ETGE = ETGE motifs, NRF2 = Nuclear factor erythroid 2-related factor 2, ARE = Antioxidant response element, HO1 = Haem oxygenase-1, GSH = Glutathione, SOD = Superoxide dismutase.
2. Nrf2-ARE signaling pathway in neuroprotection
Nrf2 is a transcription factor that stimulates a large number of cytoprotective and detoxifying genes to express them. The protective function of the Nrf2-ARE pathway in neurodegenerative conditions is illustrated by a lot of data, as it reduces ROS and neuroinflammation. An intrinsic mechanism of defense against cellular oxidative damage is the Nrf2-ARE pathway. Antioxidant enzymes are regulated by Nrf2 and proteins are involved in detoxification, repair and removal of damaged tissues and organelles and inflammation. Nrf2 blocks the transcription of proinflammatory cytokine encoding genes and suppresses proinflammatory responses after UV radiation or lipopolysacchride (LPS) exposure. A variety of antioxidant enzymes and proteins that exert cytoprotective enhancement of neurological phenotypes in disease models after the induction of antioxidant activities based on Nrf2 are expressed in the Nrf2 Regulations. The levels of Nrf2 are primarily regulated by ubiquitination and proteosomal degradation. Activation of Nrf2 contributes to upregulation of proteins involved in the synthesis of glutathione, the major antioxidant intracellular small molecule, and nicotinamide adenine dinucleotide phosphate (NADPH), which produces oxidised glutathione disulfide (GSSG) reduction equivalents for the regeneration of reduced glutathione (GSH). Nrf2 activation counterbalances mitochondrial ROS production and defends toxins released by mitochondria [13, 14]. Similarly, in numerous in vitro and in vivo studies, other researchers have tested the neuroprotective efficacy of ARE-Nrf2 pathways and it has been shown that many natural and synthetic compounds exhibit profound neuroprotective effects based on Nrf2-ARE. It was therefore assessed that the chemically induced ARE-mediated transcriptional response as well as the chemo preventive efficacy of these compounds is absolutely abolished in Nrf2 knock-out mice and Nrf2 disrupted cells [15, 16].
3. Role of Nrf2 signaling in countering neurodegenerative diseases
The important global health issues associated with ageing are neurodegenerative diseases. For different neurodegenerative diseases underlying ROS overproduction and inflammation, pharmacological activation of Nrf2 is a promising therapeutic strategy. Via upregulation of antioxidant defenses, inflammation inhibition, enhancement of mitochondrial function and maintenance of protein homeostasis, Nrf2 activation mitigates several pathogenic processes involved in neurodegenerative diseases. Enhanced antioxidant activities based on Nrf2 play a crucial role in the pathological enhancement of neurodegenerative diseases, as Nrf2 controls the expression of a spectrum of antioxidant enzymes and proteins [17]. Nrf2 has been involved in the regulation of the mechanism of cellular defense by altering mitochondrial function. Enabled Nrf2 preserves ROS mitochondrial production and protects it from toxins released by mitochondria [18]. The involvement of Nrf2 signalling in the maintenance of inflammatory mediator development has been identified, explaining the mechanism of transcriptional repression of pro-inflammatory cytokines (TNF-alpha, IL-1, IL6, IL-8, MCP-1) in microglia, macrophages, monocytes and astrocytes after activation of Nrf2 [19].
In neurodegenerative disorders, Nrf2-HO-1 is downregulated [17, 20]. These are the primary cellular mechanisms which regulate genes that are antioxidant and cytoprotective. In multiple pathological disorders such as Alzheimer's disease, Parkinson 's disease etc., neuroprotective activity of Nrf2 mediated haemoxygenase1 (HO-1) induction has been demonstrated [21]. The rate-limiting enzyme, HO-1, is closely regulated by Nrf2. Promising methods for the initiation and development of neurodegenerative diseases are Nrf2 activation and elevation of HO-1 in microglia [22]. Figure 2 demonstrating about targets of Nrf2 pathway in different neurodegenerative diseases. Similarly, it has been shown that the interaction between the nuclear factor kappa-light-chain-enhancer of activated B cells controlling the production of cytokines and the NRF2-ARE system is also involved in neurodegenerative and neuroinflammatory disorders [23]. Stimulation of the ARE-mediated activity of Nrf2 can lead to suppression of the neurodegenerative process by inhibition of ROS generation and inhibition of redox-sensitive expression of inflammatory mediators, based on the available literature on the Nrf2-ARE signaling pathway. The fact that the Nrf2-ARE signaling pathway may be potential developmental therapeutic targets and the quest for new promising agents for better treatment of neurodegenerative diseases is identified [22].
Figure 2.
Nrf 2 pathway as a target in different neurodegenerative diseases. Nrf2 mediated oxidative stress and inflammations causes neuronal damages lead to deregulation of various proteins responsible for subsequent neurodegenerative diseases. Nrf 2 = Nuclear factor erythroid 2-related factor 2, GSK3β = Glycogen synthase kinase 3 beta, AD = Alzheimer's disease, PD = Parkinson's disease, HD = Huntington's disease, ALS = Amyotrophic lateral sclerosis, MS = Multiple sclerosis.
4. Natural substances induced Nrf2 activation in neurodegenerative diseases
Recent studies have shown that certain natural substances or derived compounds are capable of defending neuronal cells against oxidative stress and ameliorating various chronic diseases. In addition, few researchers have investigated the possibility of combining different herbal plants with Keap1-Nrf2 Pathway activation for the treatment of neurodegenerative disease [24]. The Table 1 contains available natural substances and their effective moiety which is responsible to activate the Nrf2 pathway and gives protection against neuroinflammatory disorders. Table 2 represent the structure of active moiety obtained from various natural sources and are responsible for modulate the activity of Nrf2 in order to produce neuroprotective action.
Table 1.
List of natural substances that modulate Nrf2 pathway in neurodegenerative diseases.
| S. No. | Compound | Botanical name | Mechanism | Model of disease | Used doses | Ref. |
|---|---|---|---|---|---|---|
| 1 | Amygdaline | Artemisia amygdalina | Artemisia amygdalina up regulates Nrf2 pathway through inhibition of KEAP1 which further leads to activation of antioxidant machinery. | in vitro N2a and SH-SY5Y cells | 100 μg/ml | [36] |
| 2 | Andalucín | Artemisia lannta | Andalucín promotes Nrf2 mediated HO-1 levels by blocking the p65-p300 interaction in LPS treated BV2 microglia. | in vitro BV2 cells | 5–20 μM | [31] |
| 3 | Andrographolide | Andrographus Paniculata | Andrographolide increases Nrf2 expression in CYS151 independent manner but likely KEAP1 dependent manner. | in vitro HEK293T cells | 7.5 μM | [34] |
| 4 | Astragaloside IV | Radix Astragali Seu Hedysari | Astragaloside IV protected the integrity of BBB in LPS induced mice, the mechanism of which might be mediated via activating Nrf2 signalling pathway | in vivo Mice | 40 μM | [83, 84] |
| 5 | Caffeic acid | Propolis Extract | Caffeic acid increases the expression of Nrf2 and HO-1, which is probably mediated by GSKβ activity. | in vivo Male C57B1/6 Mice | 10 mg/kg | [70] |
| 6 | Cannabidiol | Cannabis sativa | Activation of Nrf2-hmox1 and Nrf2/ATF4 pathways to control LPS-induced activation of microglial cells. |
in vitro BV2 cells |
10 μM | [41] |
| 7 | Cardamonin | Alpinia katsumadai | The mechanism underlying the activation of Nrf2 by CD might involve the oxidation/alkylation of key thiols in KEAP1 and/or phosphorylation of Nrf2. |
in vitro PC12 cells |
10 μM | [29] |
| 8 | Carnosic acid | Rosmarinus officinalis | Neurons protection from oxidative stress and excitotoxicity through keap1/Nrf2 transcriptional pathway | in vitro | 3 μmol/L | [88] |
| 9 | Curcumin | Curcuma longa | Protects neurons from ischemic injury through Akt/Nrf2 pathway. | in vivo | 5 mg/kg | [100] |
| 10 | Fumaric acid | Dimethyl Fumarate DMF | Fumaric acid activates Nrf2 through Modification of keap1 cysteine residue 151 and thus leads to stabilization of Nrf2. | in vivo C57/BL6 mice | 15 mg/kg | [101] |
| 11 | Hesperetin | Citrus Fruit Species | Hesperetin significantly upregulated the expression of Nrf2 and HO-1. | in vitro, HT22 and BV2 cells | 5 μM | [102] |
| 12 | Icariin | Epimedii Herba | Icariin increases the translocation of Nrf2 from cytoplasm to nucleus and also enhance the protein expression of HO-1 as well as NQO1. | in vitro BV2 cells | 0.1 μM | [103] |
| 13 | Lycopene | Solanum lycopersicum | Lycopene restore Nrf2, upregulate expression of HO-1 and BDNF in H2O2 treated SH-SY5Y cells | in vitro SH-SY5Y cells | 5 μM | [96] |
| 14 | Nardochinoid C | Nardostachys chinensis | Activation of Nrf2/HO-1 by nardochinoid c inhibit inflammation and oxidative stress in LPS activated macrophages |
in vitro RAW 264.7 cells |
20 μM | [79] |
| 15 | Narngenin | Citrus paradise | Narngenin showed neuroprotective effects against MPTP- induced oxidative stress. | Male C57BL/6J mice | 100 mg/kg | [45] |
| 16 | Quercetin | Morus alba | Quercetin counteracts neuroinflammation by activating Nrf2/HO-1 and inhibiting NF-kB signalling in SK-N-MC cell lines. | in vitro and in vivo | 20 μg/mL | [76] |
| 17 | Schisantherin A | Schisandra Sphenanthera | Schisantherin A induce accumulation of Nrf2 in the nucleus and its activation mediated by ERK phosphorylation. | in vitro BV2 cells | 50 μM | [91] |
| 18 | Sophoraflavanone G | Sophora Alopecuroides | Sophoraflavanone downregulated phosphorylated MAPK, JAK/STAT and upregulated HO-1 via Nrf2 transcription factor in LPS activated BV2 cells. | in vitro BV2 cells | 10 μM | [97] |
| 19 | Tenuigenin | Polygala Tenuifolia | Tenuigenin upregulates Nrf2 in dose dependent manner. It inhibit neuro-inflammation by upregulating the expression of keap1-Nrf2 signalling pathway. | in vitro, BV2 cells and in vivo male ICR mice | 1–4 μM 5–20 mg/kg |
[82] |
Table 2.
Structures of natural compounds obtained from herbal sources and effective in neuroprotection by acting through Nrf2 pathway.
4.1. Alpinia katsumadai
Cardamonin (CD) is chalconoid which belongs to the Zingiberaceous family, isolated from Alpinia species such as Alpinia katsumadai. A broad range of pharmacological activities such as antioxidant, anti-inflammatory, antineoplastic, anti-infectious, vasorelaxant, hypoglycaemic and autophagy induction have been investigated [25]. It has been documented in recent studies that CD is an efficient small molecule activator of Nrf2. The study paper indicated that the mechanisms underlying CD activation of Nrf2 might include the oxidation/alkylation of main thiols in Keap1 and/or Nrf2 phosphorylation [26, 27]. Some other study findings showed that neuroinflammation was caused by dose-dependently CD upregulated phase11 enzymes governed by Nrf2 in PC12 cells with H2O2. This promotes the use of CD as a possible candidate for the prevention of neurodegenerative diseases induced by oxidative stress prevention [28, 29].
4.2. Andrographus paniculata
Andrographalide was isolated from the plant Andrographus paniculata, a major labdane diterpenoid commonly known as Kalmegh [30]. It is an herbaceous plant belonging to the family Acanthaceae. Immunostimulatory, antitumor, antibacterial, antidiabetic, and neuroprotective activities in the treatment of stroke have been recorded [31]. Andrographalide upregulates of the Nrf2 route have been documented in recent studies. Effects of neuroprotective behaviour in the treatment of stroke were shown by Andrographalides. Upregulation of Nrf2 by andrographalide depending on the existence of cysteine residue 151 in keap1 has been documented in recent studies, resulting in keap1 dependent Nrf2 degradation [32]. Mostly, they possess an antioxidant response and produce cytoprotective results. Via activating p38 by mitogen-activated protein kinases (MAPK) and extracellular signal-regulated kinases (ERK) phosphorylation in in vitro assays, andrographolides express Nrf2 and HO-1 in astrocytes [33, 34, 35].
4.3. Artemisia amygdalina
Amygdaline is a member of the Asteraceae family of Artemisia amygdalina, a critically endangered endemic species of the Kashmir Himalayas. Anti-inflammatory, antioxidant, anti-diabetic, immunomodulatory and neuroprotective activities have already been recorded [36]. In folk medicine, it is the most commonly used medicinal herb. Amygdaline from Artemisia amygdalina induces oxidative stress against H2O2-induced toxicity in differentiated N2a and SH-SY5Y cells. Studies have shown that this plant provides neuroprotection by upregulating the Nrf2 path [37]. Activation of Nrf2 causes inhibition of keap1, which also leads to activation of the antioxidant response and induction of the neuroprotective effects of OH-1 enzymes [38, 39].
4.4. Cannabis sativa
Cannabis sativa has been known for its medicinal properties since ancient times. The key non-psychotropic constituent of Cannabis sativa is the cannabinoid. Cannabidiol (CBD), which is currently being studied as a possible therapeutic alternative for various neurodegenerative diseases. Evidence indicates that CBD has properties that are antioxidant, anti-apoptotic and neuroprotective. A substantial reduction in Aβ mediated neuronal cell death can be accounted for by CBD. Activation of microglial cells by activation of Nrf2-hmox1 and Nrf2/ATF4 pathways in LPS induced by CBD providing neuroprotectionin vitro model [40]. CBD decreases Aβ-induced neuroinflammation and facilitates hippocampal neurogenesis through PPARc participation in the Alzheimer's disease model of in vivo Sprague dawley rat. Recent research has shown that distilled CBD alone counteracts neuronal apoptosis in the multiple sclerosis experimental model [41, 42].
4.5. Citrus paradise
In citrus fruits such as Citrus paradise and Citrus sinensis, Narngenin is a strong flavonoid found to be abundant. It has strong antioxidant, anti-inflammatory and neuroprotective properties [5, 43]. The study shows that narngenin has prevented neurotoxicity caused by 6-hydroxydopamine (6-OHDA) by triggering the Nrf2-ARE signaling pathway. Another NGN research has demonstrated neuroprotective effects in the mouse model against MPTP-mediated parkinson's disease and also against toxicity induced by Aβ in PC12 nerve cells [44, 45, 46].
4.6. Citrus fruit species
Hesperetin is a flavanone glycoside and a broad variety of pharmacological activities such as antioxidant, anti-inflammatory and neuroprotective in various models of neurodegenerative diseases have been shown from hesperidin contained in citrus fruit organisms [47]. Recent studies have indicated that hesperetin hinders initiation, neuroinflammation progression and may act as a potential neuroprotective agent against neurodegenerative diseases such as alzheimer's disease, memory decline [48]. Recent studies have indicated that hesperetin confers neuroprotection in the Aβ mouse model for alzheimer's disease by controlling NRF2/TLR4/NF-kB signaling [49].
4.7. Curcuma longa
The main active ingredient of Curcuma longa, widely used as a turmeric powder, is curcumin. Epidemiological studies have shown that the occasional dietary consumption of turmeric in rural areas of India decreases the incidence of Alzheimer's disease. 5–30 μM curcumin has been shown to suppress Aβ in the transgenic mouse model of Alzheimer's disease [50]. The study found that curcumin could reduce the expression of IL-1β, IL-6 and TNF-alpha induced by Aβ 42 in microglia, depending on its concentration [51]. In an in vitro model of ischemia/reperfusion, curcumin has neuronal defense against oxidative stress and inflammation by inducing Nrf2 activation and HO-1 expression in the PI3K/Akt pathway activation system. Recent studies have shown that curcumin defends PC12 cell lines against in vitro and in vivo models of cholesterol-induced neurotoxicity [52]. Curcumin was found to suppress TNF-alpha and caspase3 levels, the neuroinflammatory mediators, by growing BDNF levels in another research rat model of olfactory-bulb ablation [53].
4.8. Dimethyl fumarate
Dimethyl fumarate (DMF) is a trans-butenedioic acid, an alkylating metabolite that occurs naturally. This is an electrophilic compound [54] which is reported to have neuroprotective and immunomodulatory properties through Nrf2 activation [55]. It (DMF; Tecfidera/BG-12) has recently been approved by the FDA for multiple sclerosis therapy, commonly referred to as BG-12, on the basis of its neuroprotective and anti-inflammatory impact [56]. A further research study showed that DMF activates the Nrf2 pathway by depleting intracellular GSH levels and reducing dose-dependent cell viability via the S-alkylation mechanism to generate neuroprotection by up-regulating antioxidant response in MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced experimental parkinson-like disease model MPTP [57].
4.9. Elephantopus scaber
Elephantopus scaber (ESEAF), usually referred to as the foot of an elephant, is a folk medicine typically used for wound healing, fever and hepatoprotective agents. It has many functions, such as anti-cancer, anti-diabetic, anti-inflammatory and antioxidant properties. It has been scientifically proven in different in vivo models to show anti-inflammatory and antioxidant impact. Scientific research, however, has shown that ESEAF exhibits anti-neuroinflammatory effects on LPS-induced neuronal immune cell (BV2) inflammation. Activation of the Nrf2/HO-1 pathway by ESEAF has been reported to reduce oxidative stress and inflammation in neurodegenerative diseases [58]. This indicates that by inducing activation of Nrf2/HO-1 protein expression, ESEAF demonstrates anti-neuroinflammatory impact. The potential for developing ESEAF as a potential therapeutic agent for the treatment of microglial induced neuroinflammatory diseases has therefore been further substantiated by these results [59, 60].
4.10. Epimedii herba
Icariin (ICA) is a natural flavonoid extracted from the Epimedium Herba species, a Chinese herbal medicine known as Ying Yang Huo [61]. It displays a number of pharmacological activities such as antioxidants, anti-inflammatory, anti-aging [62]. Recent studies show that by activating the Nrf2 signalling pathway, ICA granted neuroprotective safety against brain ischemic injury and neurodegenerative diseases [63]. ICA decreases neuroinflammation and exerts Nrf2 pathway dopamine neuroprotection and also improves neurogenesis, enhancing unique working memory. A further research paper reported that by triggering the antioxidant defense, ICA exercised neuroprotection against oxygen-glucose deprivation-induced neurotoxicity. Furthermore, ICA enhanced the unique learning and memory capacities of rats in LPS-induced brain dysfunction by reducing proinflammatory mediators [64].
4.11. Zingiber officinale
Ginger has been generally utilized as a well known zest or food supplement and has been similarly rumored for its therapeutic properties for quite a long time. 6-Dehydrogingerdione (6-DG), one of the significant parts of dietary ginger, has gotten broad consideration because of its different pharmacological exercises, for example, restraint of lipid peroxidation [65]. 6-DG is viable in forestalling oxidative pressure prompted neuronal cell harm. Its neuroprotection include its ability in straightforwardly killing free revolutionaries and actuating endogenous cell cancer prevention agent guard. Its hydroxyl bunch is basic for the immediate cancer prevention agent movement, though the, β-unsaturated ketone structure is fundamental for initiation of the Keap1-Nrf2-ARE pathway in cells [66].
4.12. Honey bee hives
Caffeic acid phenethyl ester (CAPE) is a main active component of propolis extract, commonly called phenyl ethyl caffeate, which is derived from honey bee hives. Various biological activities have been shown to have diverse effects, such as antimicrobial, anti-inflammatory, antitumor, antiviral, cytotoxic, anti-carcinogenic, immunomodulatory and neuroprotective [67]. The available studies indicate that it is an efficient moiety against various pathologies such as inflammation, oxidative stress, cancer, diabetes, neurodegeneration and anxiety, according to the literature quest. Studies have shown that CAPE has neuroprotective operation [68]. Nuclear factor erythroid 2-related factor 2 (Nrf2) is released after stimulation with CAPE from its suppressor Kelch-like ECH-associated protein 1 (Keap1) and translocated to the nucleus, activating expression of HO-1 leading to neuroprotection. In addition, anti-inflammatory effects are provided by NF-kBinhibition [69, 70].
4.13. Inula helenium
Costunolide (COS) is a natural sesquiterpene lactone originally isolated from Inula helenium (Compositae). Costunolide (COS) belongs to the sesquiterpene lactone family and is abundant in Compositae, such as Laurus nobilis and Saussurea lappa. It has been reported that COS exhibits a range of pharmacological properties. It has been shown that COS provides neuroprotection via activating the Nrf2 signaling pathway in PC12 cells. Furthermore, COS attenuates the cellular reactive oxygen species level and restores cellular thiol homeostasis, supporting that COS was involved in maintaining the cellular redox balance [71].
4.14. Loranthus parasiticus merr
Loranthus parasiticus Merr is an essential traditional Chinese medicinal plant known as Sang ji sheng in Chinese and belongs to the Loranthaceae family [72]. Important pharmacological activities such as neuroprotective, tranquillizing, anticancer, antihepatotoxic, diuretic, immunomodulatory, antioxidant and anti-nephrotoxicity activities have been shown through different studies to date [72, 73]. Latest researches have stated that two types of L. parasiticus LPEE (L. parasiticus ethanol extract) and L. parasitic saqueous fraction (L. parasitic saqueous fraction) have been evaluated and demonstrated dose-dependent antioxidant properties through Nrf2/HO-1 protein expression and neuroprotective activity on NG-108-15 hybridoma cells against induced free radicle generation [74, 75].
4.15. Morus Alba
Quercetin is a significant glycoside of flavonol derived from Morus Alba, generally referred to as mulberry. It has antioxidant properties and is anti-inflammatory. This enhances neuroprotection by scavenging free radicals through their antioxidant properties. It has been studied as a lead compound exhibiting neuroprotective effects in the animal model of neurodegeneration because of its anti-inflammatory property. Recently, neuroinflammation-associated markers induced by quercetin attenuated LPS counteract neuroinflammation by activating Nrf2/HO-1 and inhibitory NF-kB signalling in SK-N-MC cell lines in both in vitro and in vivo models [76].
4.16. Nardostachys Chinensis
Nardochinoid C (DC) is a new Nardostachys Chinensis isolated compound. Neuroprotection and cardiovascular effects occur in the roots and rhizomes of Nardostachys Chinensis. It has antioxidant properties and anti-inflammatory properties. Recent studies have shown that DC substantially decreases oxidative stress and releases macrophages triggered by LPS proinflammatory mediators [77, 78]. Mechanism studies have reported that DC activated the Nrf2 signalling pathway primarily, increased antioxidant protein HO-1 levels and thus induced anti-inflammatory antioxidant effects. The activation of the antioxidant pathway mediated by Nrf2 has a neuroprotective effect, and antioxidants can promote the anti-inflammatory effects of DC [79].
4.17. Olives
Hydroxytyrosol (3,4-dihydroxyphenylethanol), a normally happening polyphenol in table olives and other dietary plants, is available in an especially high fixation either in a free or esterified structure in additional virgin olive oils, wherein it represents up to 70%–80% of the absolute phenolic portions [80]. Hydroxytyrosol gives double neuroprotection and cell cancer prevention agent guard as both a free extreme forager and Nrf2 activator, recommending the likely drug utilization of HT for the therapy of neurodegenerative issues [81].
4.18. Polygala Tenuifolia
Tenuigenin is a bioactive component that is mostly recognised from the roots of Polygala Tenuifolia and has pharmacological activities such as anti-inflammatory effects. It has recently been stated by Xiaokun Wang that TGN activates the dose-dependent Nrf2-ARE pathway, which is subsequently upregulated by HO-1. These findings suggest that TGN induces anti-inflammatory effects by Nrf2-ARE pathway activation. TGN activation of Nrf2 decreases inflammation and cytokines in brain tissue [82].
4.19. Radix astragali seu hedysari
Radix astragali seu hedysari (huangqi), an essential herb widely used in traditional Chinese medicine, is a major component of Astragaloside IV. The paper by H.L wang et al, review evaluated the recent findings on the neuroprotective effects of astragaloside IV. They suggest based on their review, that astragaloside IV enhances neurological deficits in the experimental model of cerebral ischemia. Results showed that astragaloside IV preserved the integrity of BBB in mice induced by LPS, whose function could be regulated by the activation of the Nrf2 signalling pathway. Such results indicated that astragaloside IV could be a potent neuroprotective drug [83, 84].
4.20. Rosmarinic acid
Rosmarinic acid, a polyphenolic phytochemical compound, is commonly used as a flavouring agent and preservative in the food industry. It has properties that are anti-oxidative, anti-viral, immunomodulatory and anti-apoptotic. Some preclinical studies have shown that Rosmarinic acid provokes neuroprotection through Nrf2 and HO-1 signalling in the mouse model of ischaemic stroke. The activation of the Akt/Nrf2/HO-1 pathway provides rosmarinic acid with a valuable target to protect the brain against acute ischaemic injury. HO-1 has been highlighted as an important downstream Nrf2/ARE signaling pathway enzyme for its successful neuroprotection against ischemic injury and other neurodegenerative diseases [85]. In the G93A-SOD1 transgenic mouse model of ALS, another investigator showed that rosmarinic acid alleviates neurological symptoms and also protects PC12 cells from Aβ-induced neurotoxicity in the Alzheimer's disease model [86, 87].
4.21. Rosmarinus officinalis
Carnosic acid (CA) is a normal pro-electrophilic compound transformed to its active form by oxidative stress, which in turn activates transcription based on Nrf2. Carnosic acid decreased dendritic spine loss in rat neurons exposed to neurotoxic oligo metric Aβ in vitro and in vivo models, enhanced learning and memory by carnosic acid treatment of human amyloid precursor protein (hApp)-J20 mice. CA triggers the keap1/Nrf2 transcriptional pathway by S-alkylation in recent studies by binding keap1 cysteine residues, thus shielding neurons from oxidative stress and excitoxicity in both in vitro and in vivo [88].
4.22. Schisandra sphenanther
During neuroinflammation, phytochemical-induced activation of Nrf2 signalling might have a modulatory effect on activation of NF-kB. Dibenzocycloctadiene lignin, from Schisandra sphenanthera fruits, is schisantherin-A (StA). In Chinese traditional medicine, it is generally used as a sedative, tonic, antitussive. It also has anti-inflammatory effects and can have behaviors that are neuroprotective. Its anti-inflammatory activities were based on activation of Nrf2 mediated by ERK phosphorylation [89]. Recently, it has been reported that StA attenuates antioxidant response by quenching ROS and regulates phase 2 antioxidant enzymes like HO-1 by stimulating the signalling mechanism of activation Nrf2 through ERK phosphorylation and could contribute to inactivation of NF-βB pathways in microglial cells activated by LPS BV2 [90,91]. The anti-inflammatory and antioxidant effects of StA are a preventive therapeutic potential for various neurodegenerative disorders [92].
4.23. Solanum lycopersicum
Lycopene is a natural carotenoid, a polyunsaturated hydrocarbon extracted from Solanum lycopersicum. Studies show that it has many pleiotropic effects, including antioxidants, anti-inflammatory and neuroprotective activities [93, 94]. Mediating the neuroprotective effects of lycopene through inhibition of ROS development, microglial activation, PPARγ, PI3K/AtK signalling mechanisms in CNS diseases has been established. In an experimental ischaemic model, its acts were shown to be due to upregulation of the Nrf2 pathway that leads to neuroprotection. Recently an in vitro study has confirmed that lycopene decreases neuronal damage caused by Aβ exposure by enhancing mitochondrial pathogenesis in primary cultured rat cortical neurons [95]. Other research paper showed results of lycopene restoring Nrf2, upregulating HO-1 and BDNF expression in SH-SY5Y cells treated with H2O2 [96].
4.24. Sophora alopecuroides
A major flavonoid obtained from Sophora alopecuroides is Sophora flavanone G (SG). Recent studies have shown that SG ameliorate microglia mediated neuroinflammation (BV2 cells) by the signaling pathways MAPK, JAK STAT and Nrf2/HO-1. Recent study have shown that SG ameliorate microglia mediated neuroinflammation (BV2 cells) by MAPK, JAK/STAT and Nrf2/HO-1. Mechanism studies have found that in LPS activated BV2 cells, SG down regulated phosphorylated MAPK, JAK/STAT and upregulated HO-1 via Nrf2 transcription factor. This suggests that SG can have strong anti-neuroinflammatory effects [97].
4.25. Tiliroside
Tiliroside is a dietary flavonoid extracted from various edible plants present in fruits, leaves, roots, and various components. The current states of research to date shows that 172 plant species come from 35 different families have been described. Antioxidant, anti-inflammatory, antidiabetic, anti-allergic, heptoprotective, anti-microbial, anti-proliferative, anti-neuroprotective activities have been documented in studies [98]. A new study shows that by targeting Nrf2 antioxidant pathways, tiliroside protected BV2 microglia from LPS/IFNγ mediated neuroinflammation and HT22 neuronal toxicity. Via the Nrf2 pathway, tiliroside greatly improves HO-1/NQO1 proteins and contributes to neuroprotection. In mouse hippocampal neurons, it also inhibits the NF-kB via SIRT1 pathway [99].
5. Conclusion
In different neurodegenerative diseases, neuroinflammation is a major process that has been widely described. In recent years, the Nrf2-ARE response has been described in many neurodegenerative diseases as a dysfunction of the cellular response to oxidative stress and neuroinflammation. The activation of the Nrf2-ARE pathway has therefore been identified as a key target for the development of new medicines for neurodegenerative diseases. In this sense, natural substances, which have been studied in recent years, are important sources of Nrf2 activators. Compounds examined here have shown promising results in in vitro and in vivo models that protect neurons from inflammation and oxidative stress. The anti-inflammatory, antioxidant and Nrf2 activating properties of these substances tested were connected to these findings. In conclusion, the first-line idea of the activation of Nrf2 was to use the Nrf2-ARE pathway as a main target to find real disease modifying drugs for neurodegenerative diseases. In summary, this study includes a variety of subjects concerned with the neuroprotective effects of different natural substances by stimulating the Nrf2-ARE pathway.
Declarations
Author contribution statement
All authors listed have significantly contributed to the investigation, development and writing of this article.
Funding statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Data availability statement
No data was used for the research described in the article.
Declaration of interests statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
References
- 1.Stephenson J., Nutma E., van der Valk P., Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204–219. doi: 10.1111/imm.12922. PubMed PMID: 29513402. Epub 2018/04/17. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2):154–169. doi: 10.1111/j.1365-2567.2009.03225.x. PubMed PMID: 20561356. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.DiSabato D.J., Quan N., Godbout J.P. Neuroinflammation: the devil is in the details. J. Neurochem. 2016 Oct;139(Suppl 2):136–153. doi: 10.1111/jnc.13607. PubMed PMID: 26990767. PMCID: PMC5025335. Epub 2016/11/01. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Milatovic D., Zaja-Milatovic S., Breyer R.M., Aschner M., Montine T.J. Chapter 64 - neuroinflammation and oxidative injury in developmental neurotoxicity. In: Gupta R.C., editor. Reproductive and Developmental Toxicology. Academic Press; San Diego: 2011. pp. 847–854. [Google Scholar]
- 5.Shal B., Ding W., Ali H., Kim Y.S., Khan S. Anti-neuroinflammatory potential of natural products in attenuation of alzheimer's disease. Front. Pharmacol. 2018;9:548. doi: 10.3389/fphar.2018.00548. PubMed PMID: 29896105. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Habtemariam S. The Nrf2/HO-1 Axis as targets for flavanones: neuroprotection by pinocembrin, naringenin, and eriodictyol. Oxid. Med. Cell. Long. 2019;2019:4724920. doi: 10.1155/2019/4724920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Robledinos-Antón N., Fernández-Ginés R., Manda G., Cuadrado A. Activators and inhibitors of NRF2: a review of their potential for clinical development. Oxid. Med. Cell. Long. 2019;2019:9372182. doi: 10.1155/2019/9372182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shal B., Ding W., Ali H., Kim Y.S., Khan S. Anti-neuroinflammatory potential of natural products in attenuation of alzheimer's disease. Front. Pharmacol. 2018;9:548. doi: 10.3389/fphar.2018.00548. PubMed PMID: 29896105. PMCID: PMC5986949. Epub 2018/06/14. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tonelli C., Chio I.I.C., Tuveson D.A. Transcriptional regulation by Nrf2. Antioxidants Redox Signal. 2018;29(17):1727–1745. doi: 10.1089/ars.2017.7342. PubMed PMID: 28899199. Epub 2017/10/20. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Deshmukh P., Unni S., Krishnappa G., Padmanabhan B. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys. Rev. 2017;9(1):41–56. doi: 10.1007/s12551-016-0244-4. PubMed PMID: 28510041. Epub 2016/12/06. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Johnson D.A., Johnson J.A. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases. Free Radic. Biol. Med. 2015 Nov;88(Pt B):253–267. doi: 10.1016/j.freeradbiomed.2015.07.147. PubMed PMID: 26281945. PMCID: PMC4809057. Epub 2015/08/19. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Schmidlin C.J., Dodson M.B., Madhavan L., Zhang D.D. Redox regulation by NRF2 in aging and disease. Free Radic. Biol. Med. 2019 Apr;134:702–707. doi: 10.1016/j.freeradbiomed.2019.01.016. PubMed PMID: 30654017. PMCID: PMC6588470. Epub 2019/01/18. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009 May 15;284(20):13291–13295. doi: 10.1074/jbc.R900010200. PubMed PMID: 19182219. PMCID: PMC2679427. Epub 2009/02/03. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tu W., Wang H., Li S., Liu Q., Sha H. The anti-inflammatory and anti-oxidant mechanisms of the keap1/Nrf2/ARE signaling pathway in chronic diseases. Aging Dis. 2019 Jun;10(3):637–651. doi: 10.14336/AD.2018.0513. PubMed PMID: 31165007. PMCID: PMC6538222. Epub 2019/06/06. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zhang N., Shu H.-Y., Huang T., Zhang Q.-L., Li D., Zhang G.-Q. Nrf2 signaling contributes to the neuroprotective effects of urate against 6-OHDA toxicity. PloS One. 2014;9(6) doi: 10.1371/journal.pone.0100286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Huang Y., Li W., Su Z-y, Kong A.-N.T. The complexity of the Nrf2 pathway: beyond the antioxidant response. J. Nutr. Biochem. 2015;26(12):1401–1413. doi: 10.1016/j.jnutbio.2015.08.001. PubMed PMID: 26419687. Epub 2015/08/08. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Dinkova-Kostova A.T., Kostov R.V., Kazantsev A.G. The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J. 2018 Oct;285(19):3576–3590. doi: 10.1111/febs.14379. PubMed PMID: 29323772. PMCID: PMC6221096. Epub 2018/01/13. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Esteras N., Dinkova-Kostova A.T., Abramov A.Y. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function. Biol. Chem. 2016 May;397(5):383–400. doi: 10.1515/hsz-2015-0295. PubMed PMID: 26812787. Epub 2016/01/27. eng. [DOI] [PubMed] [Google Scholar]
- 19.Kobayashi E.H., Suzuki T., Funayama R., Nagashima T., Hayashi M., Sekine H. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 2016 May 23;7:11624. doi: 10.1038/ncomms11624. PubMed PMID: 27211851. PMCID: PMC4879264. Epub 2016/05/24. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tavakkoli A., Iranshahi M., Hasheminezhad S.H., Hayes A.W., Karimi G. The neuroprotective activities of natural products through the Nrf2 upregulation. Phytother Res. 2019;33(9):2256–2273. doi: 10.1002/ptr.6427. [DOI] [PubMed] [Google Scholar]
- 21.Paladino S., Conte A., Caggiano R., Pierantoni G.M., Faraonio R. Nrf2 pathway in age-related neurological disorders: insights into MicroRNAs. Cell. Physiol. Biochem. 2018;47(5):1951–1976. doi: 10.1159/000491465. PubMed PMID: 29969760. Epub 2018/07/04. eng. [DOI] [PubMed] [Google Scholar]
- 22.Lu M.C., Ji J.A., Jiang Z.Y., You Q.D. The keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med. Res. Rev. 2016 Sep;36(5):924–963. doi: 10.1002/med.21396. PubMed PMID: 27192495. Epub 2016/05/19. eng. [DOI] [PubMed] [Google Scholar]
- 23.Sivandzade F., Prasad S., Bhalerao A., Cucullo L. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches. Redox Biol. 2019 Feb;21:101059. doi: 10.1016/j.redox.2018.11.017. PubMed PMID: 30576920. PMCID: PMC6302038. Epub 2018/12/24. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Choi J.H., Jang M., Lee J.-I., Chung W.-S., Cho I.-H. Neuroprotective effects of a traditional multi-herbal medicine kyung-ok-ko in an animal model of Parkinson's disease: inhibition of MAPKs and NF-κB pathways and activation of keap1-Nrf2 pathway. Front. Pharmacol. 2018;9:1444. doi: 10.3389/fphar.2018.01444. PubMed PMID: 30618742. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gonçalves L.M., Valente I.M., Rodrigues J.A. An overview on cardamonin. J. Med. Food. 2014;17(6):633–640. doi: 10.1089/jmf.2013.0061. PubMed PMID: 24433078. Epub 2014/01/16. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.De Spirt S., Eckers A., Wehrend C., Micoogullari M., Sies H., Stahl W. Interplay between the chalcone cardamonin and selenium in the biosynthesis of Nrf2-regulated antioxidant enzymes in intestinal Caco-2 cells. Free Radic. Biol. Med. 2016 Feb;91:164–171. doi: 10.1016/j.freeradbiomed.2015.12.011. PubMed PMID: 26698667. Epub 2015/12/25. eng. [DOI] [PubMed] [Google Scholar]
- 27.Hatziieremia S., Gray A.I., Ferro V.A., Paul A., Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br. J. Pharmacol. 2006;149(2):188–198. doi: 10.1038/sj.bjp.0706856. PubMed PMID: 16894344. Epub 2006/08/07. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Zhang J., Sikka S., Siveen K.S., Lee J.H., Um J.-Y., Kumar A.P. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer. Apoptosis. 2017 January 01;22(1):158–168. doi: 10.1007/s10495-016-1313-7. [DOI] [PubMed] [Google Scholar]
- 29.Peng S., Hou Y., Yao J., Fang J. Activation of Nrf2-driven antioxidant enzymes by cardamonin confers neuroprotection of PC12 cells against oxidative damage. Food Funct. 2017 Mar 22;8(3):997–1007. doi: 10.1039/c7fo00054e. PubMed PMID: 28271112. Epub 2017/03/09. eng. [DOI] [PubMed] [Google Scholar]
- 30.Wong D.P.W., Ng M.Y., Leung J.Y., Boh B.K., Lim E.C., Tan S.H. Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes. PloS One. 2018;13(10) doi: 10.1371/journal.pone.0204853. PubMed PMID: 30273379. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wang X., Gai Y.N., Li B.B., Huang L.L. Andalucin from Artemisia lannta suppresses the neuroinflammation via the promotion of Nrf2-mediated HO-1 levels by blocking the p65-p300 interaction in LPS-activated BV2 microglia. Phytomedicine. 2018 Dec 1;51:226–232. doi: 10.1016/j.phymed.2018.06.014. PubMed PMID: 30466621. Epub 2018/11/24. eng. [DOI] [PubMed] [Google Scholar]
- 32.Lim J.C., Chan T.K., Ng D.S., Sagineedu S.R., Stanslas J., Wong W.S. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin. Exp. Pharmacol. Physiol. 2012 Mar;39(3):300–310. doi: 10.1111/j.1440-1681.2011.05633.x. PubMed PMID: 22017767. Epub 2011/10/25. eng. [DOI] [PubMed] [Google Scholar]
- 33.Yang C.-H., Yen T.-L., Hsu C.-Y., Thomas P.-A., Sheu J.-R., Jayakumar T. Multi-targeting andrographolide, a novel NF-κB inhibitor, as a potential therapeutic agent for stroke. Int. J. Mol. Sci. 2017;18(8):1638. doi: 10.3390/ijms18081638. PubMed PMID: 28749412. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wong D.P.W., Ng M.Y., Leung J.Y., Boh B.K., Lim E.C., Tan S.H. Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes. PloS One. 2018;13(10) doi: 10.1371/journal.pone.0204853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Wong S.Y., Tan M.G., Wong P.T., Herr D.R., Lai M.K. Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK. J. Neuroinflammation. 2016 Sep 23;13(1):251. doi: 10.1186/s12974-016-0723-3. PubMed PMID: 27663973. PMCID: PMC5034653. Epub 2016/09/25. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sajjad N., Wani A., Sharma A., Ali R., Hassan S., Hamid R. Artemisia amygdalina upregulates Nrf2 and protects neurons against oxidative stress in alzheimer disease. Cell. Mol. Neurobiol. 2019 Apr;39(3):387–399. doi: 10.1007/s10571-019-00656-w. PubMed PMID: 30725250. Epub 2019/02/07. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Mubashir K., Ganai B.A., Ghazanfar K., Akbar S., Malik A.H., Masood A. Evaluation of Artemisia amygdalina D. For anti-inflammatory and immunomodulatory potential. ISRN Inflam. 2013;2013:5. doi: 10.1155/2013/483646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Skowyra M., Gallego M.G., Segovia F., Almajano M.P. Antioxidant properties of Artemisia annua extracts in model food emulsions. Antioxidants (Basel) 2014;3(1):116–128. doi: 10.3390/antiox3010116. PubMed PMID: 26784667. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ghazanfar K., Ganai B.A., Akbar S., Mubashir K., Dar S.A., Dar M.Y. Antidiabetic activity of Artemisia amygdalina decne in streptozotocin induced diabetic rats. BioMed Res. Int. 2014;2014:10. doi: 10.1155/2014/185676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.da Silva V.K., de Freitas B.S., Garcia R.C.L., Monteiro R.T., Hallak J.E., Zuardi A.W. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload. Transl. Psychiatry. 2018 Sep 3;8(1):176. doi: 10.1038/s41398-018-0232-5. PubMed PMID: 30177808. PMCID: PMC6120904. Epub 2018/09/05. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Juknat A, Kozela E, Kaushansky N, Mechoulam R, Vogel Z. Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells. J. Basic Clin. Physiol. Pharmacol.. p. 289. [DOI] [PubMed]
- 42.Esposito G., Scuderi C., Valenza M., Togna G.I., Latina V., De Filippis D. Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PloS One. 2011;6(12) doi: 10.1371/journal.pone.0028668. PubMed PMID: 22163051. PMCID: PMC3230631. Epub 2011/12/14. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Fu Y., Yang J., Wang X., Yang P., Zhao Y., Li K. Herbal compounds play a role in neuroprotection through the inhibition of microglial activation. J. Immunol. Res. 2018;2018:8. doi: 10.1155/2018/9348046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Bai X., Zhang X., Chen L., Zhang J., Zhang L., Zhao X. Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-kappaB, MMP-9 and up-regulated claudin-5 expression. Neurochem. Res. 2014 Aug;39(8):1405–1415. doi: 10.1007/s11064-014-1326-y. PubMed PMID: 24842554. Epub 2014/05/21. eng. [DOI] [PubMed] [Google Scholar]
- 45.Sugumar M., Sevanan M., Sekar S. Neuroprotective effect of naringenin against MPTP-induced oxidative stress. Int. J. Neurosci. 2019 Jun;129(6):534–539. doi: 10.1080/00207454.2018.1545772. PubMed PMID: 30433834. Epub 2018/11/16. eng. [DOI] [PubMed] [Google Scholar]
- 46.Heo hj, Kim D.-O., Shin S., Kim M., Kim B., Shin D. Effect of antioxidant flavanone, naringenin, from citrus junos on neuroprotection. J. Agric. Food Chem. 2004 04/01;52:1520–1525. doi: 10.1021/jf035079g. [DOI] [PubMed] [Google Scholar]
- 47.Hajialyani M., Hosein Farzaei M., Echeverría J., Nabavi S.M., Uriarte E., Sobarzo-Sánchez E. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules. 2019;24(3):648. doi: 10.3390/molecules24030648. PubMed PMID: 30759833. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Yang H.L., Chen S.C., Senthil Kumar K.J., Yu K.N., Lee Chao P.D., Tsai S.Y. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach. J. Agric. Food Chem. 2012 Jan 11;60(1):522–532. doi: 10.1021/jf2040675. PubMed PMID: 22098419. Epub 2011/11/22. eng. [DOI] [PubMed] [Google Scholar]
- 49.Ikram M., Muhammad T., Rehman S.U., Khan A., Jo M.G., Ali T. Hesperetin confers neuroprotection by regulating Nrf2/TLR4/NF-κB signaling in an Aβ mouse model. Mol. Neurobiol. 2019 Sep;56(9):6293–6309. doi: 10.1007/s12035-019-1512-7. PubMed PMID: 30756299. Epub 2019/02/14. eng. [DOI] [PubMed] [Google Scholar]
- 50.González-Reyes S., Guzmán-Beltrán S., Medina-Campos O.N., Pedraza-Chaverri J. Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxid. Med. Cell. Long. 2013;2013:801418. doi: 10.1155/2013/801418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Shi X., Zheng Z., Li J., Xiao Z., Qi W., Zhang A. Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: involvement of ERK1/2 and p38 signaling pathways. Neurosci. Lett. 2015 May 6;594:105–110. doi: 10.1016/j.neulet.2015.03.045. PubMed PMID: 25818332. Epub 2015/03/31. eng. [DOI] [PubMed] [Google Scholar]
- 52.Yang X., Jiang H., Shi Y. Upregulation of heme oxygenase-1 expression by curcumin conferring protection from hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblasts. Cell Biosci. 2017;7:20. doi: 10.1186/s13578-017-0146-6. PubMed PMID: 28439402. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Rinwa P., Kumar A., Garg S. Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PloS One. 2013;8(4) doi: 10.1371/journal.pone.0061052. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 54.Albrecht P., Bouchachia I., Goebels N., Henke N., Hofstetter H.H., Issberner A. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J. Neuroinflammation. 2012 Jul 7;9:163. doi: 10.1186/1742-2094-9-163. PubMed PMID: 22769044. PMCID: PMC3419128. Epub 2012/07/10. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Linker R.A., Lee D.H., Ryan S., van Dam A.M., Conrad R., Bista P. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011 Mar;134(Pt 3):678–692. doi: 10.1093/brain/awq386. PubMed PMID: 21354971. Epub 2011/03/01. eng. [DOI] [PubMed] [Google Scholar]
- 56.Cho H., Hartsock M.J., Xu Z., He M., Duh E.J. Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion. J. Neuroinflammation. 2015;12(1):239. doi: 10.1186/s12974-015-0452-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Bomprezzi R. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther. Adv. Neurol. Disord. 2015;8(1):20–30. doi: 10.1177/1756285614564152. PubMed PMID: 25584071. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Chan C.K., Tan L.T., Andy S.N., Kamarudin M.N.A., Goh B.H., Kadir H.A. Anti-neuroinflammatory activity of elephantopus scaber L. Via activation of Nrf2/HO-1 signaling and inhibition of p38 MAPK pathway in LPS-induced microglia BV-2 cells. Front. Pharmacol. 2017;8:397. doi: 10.3389/fphar.2017.00397. PubMed PMID: 28680404. PMCID: PMC5478732. Epub 2017/07/07. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Daisy P., Jasmine R., Ignacimuthu S., Murugan E. A novel steroid from Elephantopus scaber L. an ethnomedicinal plant with antidiabetic activity. Phytomedicine. 2009 Mar;16(2-3):252–257. doi: 10.1016/j.phymed.2008.06.001. PubMed PMID: 18693100. Epub 2008/08/12. eng. [DOI] [PubMed] [Google Scholar]
- 60.Hung H.F., Hou C.W., Chen Y.L., Lin C.C., Fu H.W., Wang J.S. Elephantopus scaber inhibits lipopolysaccharide-induced liver injury by suppression of signaling pathways in rats. Am. J. Chin. Med. 2011;39(4):705–717. doi: 10.1142/S0192415X11009147. PubMed PMID: 21721151. Epub 2011/07/02. eng. [DOI] [PubMed] [Google Scholar]
- 61.Tan H.L., Chan K.G., Pusparajah P., Saokaew S., Duangjai A., Lee L.H. Anti-cancer properties of the naturally occurring aphrodisiacs: icariin and its derivatives. Front. Pharmacol. 2016;7:191. doi: 10.3389/fphar.2016.00191. PubMed PMID: 27445824. PMCID: PMC4925704. Epub 2016/07/23. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Liu B., Xu C., Wu X., Liu F., Du Y., Sun J. Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience. 2015 May 21;294:193–205. doi: 10.1016/j.neuroscience.2015.02.053. PubMed PMID: 25791226. Epub 2015/03/21. eng. [DOI] [PubMed] [Google Scholar]
- 63.Li X.-A., Ho Y.-S., Chen L., Hsiao W.L.W. The protective effects of icariin against the homocysteine-induced neurotoxicity in the primary embryonic cultures of rat cortical neurons. Molecules. 2016;21(11):1557. doi: 10.3390/molecules21111557. PubMed PMID: 27879670. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Mo Z.T., Li W.N., Zhai Y.R., Gao S.Y. The effects of icariin on the expression of HIF-1alpha, HSP-60 and HSP-70 in PC12 cells suffered from oxygen-glucose deprivation-induced injury. Pharm. Biol. 2017 Dec;55(1):848–852. doi: 10.1080/13880209.2017.1281968. PubMed PMID: 28140748. PMCID: PMC6130580. Epub 2017/02/01. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Grzanna R., Lindmark L., Frondoza C.G. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food. 2005 Summer;8(2):125–132. doi: 10.1089/jmf.2005.8.125. PubMed PMID: 16117603. Epub 2005/08/25. eng. [DOI] [PubMed] [Google Scholar]
- 66.Yao J., Ge C., Duan D., Zhang B., Cui X., Peng S. Activation of the phase II enzymes for neuroprotection by ginger active constituent 6-dehydrogingerdione in PC12 cells. J. Agric. Food Chem. 2014 Jun 18;62(24):5507–5518. doi: 10.1021/jf405553v. PubMed PMID: 24869427. Epub 2014/05/30. eng. [DOI] [PubMed] [Google Scholar]
- 67.Tolba M.F., Azab S.S., Khalifa A.E., Abdel-Rahman S.Z., Abdel-Naim A.B. Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects. IUBMB Life. 2013 Aug;65(8):699–709. doi: 10.1002/iub.1189. PubMed PMID: 23847089. Epub 2013/07/13. eng. [DOI] [PubMed] [Google Scholar]
- 68.Tsai C.F., Kuo Y.H., Yeh W.L., Wu C.Y., Lin H.Y., Lai S.W. Regulatory effects of caffeic acid phenethyl ester on neuroinflammation in microglial cells. Int. J. Mol. Sci. 2015 Mar 11;16(3):5572–5589. doi: 10.3390/ijms16035572. PubMed PMID: 25768341. PMCID: PMC4394493. Epub 2015/03/15. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Jazwa A., Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr. Drug Targets. 2010 Dec;11(12):1517–1531. doi: 10.2174/1389450111009011517. PubMed PMID: 20704549. Epub 2010/08/14. eng. [DOI] [PubMed] [Google Scholar]
- 70.Morroni F., Sita G., Graziosi A., Turrini E., Fimognari C., Tarozzi A. Neuroprotective effect of caffeic acid phenethyl ester in A mouse model of alzheimer's disease involves Nrf2/HO-1 pathway. Aging Dis. 2018 Aug;9(4):605–622. doi: 10.14336/AD.2017.0903. PubMed PMID: 30090650. PMCID: PMC6065293. Epub 2018/08/10. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Peng S., Hou Y., Yao J., Fang J. Activation of Nrf2 by costunolide provides neuroprotective effect in PC12 cells. Food Funct. 2019 Jul 17;10(7):4143–4152. doi: 10.1039/c8fo02249f. PubMed PMID: 31241085. Epub 2019/06/27. eng. [DOI] [PubMed] [Google Scholar]
- 72.Moghadamtousi S.Z., Kamarudin M.N., Chan C.K., Goh B.H., Kadir H.A. Phytochemistry and biology of Loranthus parasiticus Merr, a commonly used herbal medicine. Am. J. Chin. Med. 2014;42(1):23–35. doi: 10.1142/S0192415X14500025. PubMed PMID: 24467533. Epub 2014/01/29. eng. [DOI] [PubMed] [Google Scholar]
- 73.Wong D. Antioxidative and neuroprotective effects of Loranthus parasiticus (L.) Merr (Loranthaceae) against oxidative stress in NG108-15 cells. J. Med. Plants Res. 2011 11/23:5. [Google Scholar]
- 74.Wong D.Z.H., Kadir H.A. Antioxidative and neuroprotective effects of Loranthus parasiticus (L.) Merr (Loranthaceae) against oxidative stress in NG108-15 cells. J. Med. Plants Res. 2011;5(27):6291–6298. [Google Scholar]
- 75.Wong D.Z., Kadir H.A., Lee C.L., Goh B.H. Neuroprotective properties of Loranthus parasiticus aqueous fraction against oxidative stress-induced damage in NG108-15 cells. J. Nat. Med. 2012 Jul;66(3):544–551. doi: 10.1007/s11418-011-0622-y. PubMed PMID: 22318341. Epub 2012/02/10. eng. [DOI] [PubMed] [Google Scholar]
- 76.Kuo Y.C., Tsao C.W. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin. Int. J. Nanomed. 2017;12:2857–2869. doi: 10.2147/IJN.S132472. PubMed PMID: 28435263. PMCID: PMC5391167. Epub 2017/04/25. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Luo J.-F., Shen X.-Y., Lio C.K., Dai Y., Cheng C.-S., Liu J.-X. Activation of Nrf2/HO-1 pathway by Nardochinoid C inhibits inflammation and oxidative stress in lipopolysaccharide-stimulated macrophages. Front. Pharmacol. 2018;9:911. doi: 10.3389/fphar.2018.00911. PubMed PMID: 30233360. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Jeong J.-W., Cha H.-J., Han M.H., Hwang S.J., Lee D.-S., Yoo J.S. Spermidine protects against oxidative stress in inflammation models using macrophages and zebrafish. Biomol. Ther. (Seoul) 2018;26(2):146–156. doi: 10.4062/biomolther.2016.272. PubMed PMID: 28365977. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Luo J.F., Shen X.Y., Lio C.K., Dai Y., Cheng C.S., Liu J.X. Activation of Nrf2/HO-1 pathway by Nardochinoid C inhibits inflammation and oxidative stress in lipopolysaccharide-stimulated macrophages. Front. Pharmacol. 2018;9:911. doi: 10.3389/fphar.2018.00911. PubMed PMID: 30233360. PMCID: PMC6131578. Epub 2018/09/21. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Blekas G., Vassilakis C., Harizanis C., Tsimidou M., Boskou D.G. Biophenols in table olives. J. Agric. Food Chem. 2002 2002/06/01;50(13):3688–3692. doi: 10.1021/jf0115138. [DOI] [PubMed] [Google Scholar]
- 81.Peng S., Zhang B., Yao J., Duan D., Fang J. Dual protection of hydroxytyrosol, an olive oil polyphenol, against oxidative damage in PC12 cells. Food & Function. 2015;6(6):2091–2100. doi: 10.1039/c5fo00097a. [DOI] [PubMed] [Google Scholar]
- 82.Wang X., Li M., Cao Y., Wang J., Zhang H., Zhou X. Tenuigenin inhibits LPS-induced inflammatory responses in microglia via activating the Nrf2-mediated HO-1 signaling pathway. Eur. J. Pharmacol. 2017 05 01:809. doi: 10.1016/j.ejphar.2017.05.004. [DOI] [PubMed] [Google Scholar]
- 83.Costa I.M., Lima F.O.V., Fernandes L.C.B., Norrara B., Neta F.I., Alves R.D. Astragaloside IV supplementation promotes A neuroprotective effect in experimental models of neurological disorders: a systematic review. Curr. Neuropharmacol. 2019;17(7):648–665. doi: 10.2174/1570159X16666180911123341. PubMed PMID: 30207235. PMCID: PMC6712289. Epub 2018/09/13. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Li H., Wang P., Huang F., Jin J., Wu H., Zhang B. Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice. Toxicol. Appl. Pharmacol. 2018 Feb 1;340:58–66. doi: 10.1016/j.taap.2017.12.019. PubMed PMID: 29294303. Epub 2018/01/03. eng. [DOI] [PubMed] [Google Scholar]
- 85.Cui H.Y., Zhang X.J., Yang Y., Zhang C., Zhu C.H., Miao J.Y. Rosmarinic acid elicits neuroprotection in ischemic stroke via Nrf2 and heme oxygenase 1 signaling. Neural Regen. Res. 2018 Dec;13(12):2119–2128. doi: 10.4103/1673-5374.241463. PubMed PMID: 30323140. PMCID: PMC6199925. Epub 2018/10/17. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Iuvone T., De Filippis D., Esposito G., D'Amico A., Izzo A.A. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J. Pharmacol. Exp. Therapeut. 2006 Jun;317(3):1143–1149. doi: 10.1124/jpet.105.099317. PubMed PMID: 16495207. Epub 2006/02/24. eng. [DOI] [PubMed] [Google Scholar]
- 87.Seo J.S., Choi J., Leem Y.H., Han P.L. Rosmarinic acid alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurobiol. 2015 Dec;24(4):341–350. doi: 10.5607/en.2015.24.4.341. PubMed PMID: 26713081. PMCID: PMC4688333. Epub 2015/12/30. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Satoh T., Kosaka K., Itoh K., Kobayashi A., Yamamoto M., Shimojo Y. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 2008 Feb;104(4):1116–1131. doi: 10.1111/j.1471-4159.2007.05039.x. PubMed PMID: 17995931. PMCID: PMC4566957. Epub 2007/11/13. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Li X., Zhao X., Xu X., Mao X., Liu Z., Li H. Schisantherin A recovers Aβ-induced neurodegeneration with cognitive decline in mice. Physiol. Behav. 2014 Jun 10;132:10–16. doi: 10.1016/j.physbeh.2014.04.046. PubMed PMID: 24813830. Epub 2014/05/13. eng. [DOI] [PubMed] [Google Scholar]
- 90.Li D., Ci X., Li Y., Liu C., Wen Z., Jie J. Alleviation of severe inflammatory responses in LPS-exposed mice by Schisantherin A. Respir. Physiol. Neurobiol. 2014;202:24–31. doi: 10.1016/j.resp.2014.07.013. [DOI] [PubMed] [Google Scholar]
- 91.Li C., Chen T., Zhou H., Zhang C., Feng Y., Tang F. Schisantherin A attenuates neuroinflammation in activated microglia: role of Nrf2 activation through ERK phosphorylation. Cell. Physiol. Biochem. 2018;47(5):1769–1784. doi: 10.1159/000491059. PubMed PMID: 29953988. Epub 2018/06/29. eng. [DOI] [PubMed] [Google Scholar]
- 92.Ci X., Ren R., Xu K., Li H., Yu Q., Song Y. Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells. Inflammation. 2010 Apr;33(2):126–136. doi: 10.1007/s10753-009-9166-7. PubMed PMID: 20238486. Epub 2010/03/20. eng. [DOI] [PubMed] [Google Scholar]
- 93.Cervilla L.M., Blasco B., Ríos J.J., Romero L., Ruiz J.M. Oxidative stress and antioxidants in tomato (Solanum lycopersicum) plants subjected to boron toxicity. Ann. Bot. 2007;100(4):747–756. doi: 10.1093/aob/mcm156. PubMed PMID: 17660516. Epub 2007/07/28. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Li H., Deng Z., Liu R., Loewen S., Tsao R. Bioaccessibility, in vitro antioxidant activities and in vivo anti-inflammatory activities of a purple tomato (Solanum lycopersicum L.) Food Chem. 2014 Sep 15;159:353–360. doi: 10.1016/j.foodchem.2014.03.023. PubMed PMID: 24767066. Epub 2014/04/29. eng. [DOI] [PubMed] [Google Scholar]
- 95.Qu M., Jiang Z., Liao Y., Song Z., Nan X. Lycopene prevents amyloid [Beta]-Induced mitochondrial oxidative stress and dysfunctions in cultured rat cortical neurons. Neurochem. Res. 2016 Jun;41(6):1354–1364. doi: 10.1007/s11064-016-1837-9. PubMed PMID: 26816095. Epub 2016/01/28. eng. [DOI] [PubMed] [Google Scholar]
- 96.Chen D., Huang C., Chen Z. A review for the pharmacological effect of lycopene in central nervous system disorders. Biomed. Pharmacother. 2019 Mar;111:791–801. doi: 10.1016/j.biopha.2018.12.151. PubMed PMID: 30616078. Epub 2019/01/08. eng. [DOI] [PubMed] [Google Scholar]
- 97.Guo C., Yang L., Wan C.X., Xia Y.Z., Zhang C., Chen M.H. Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways. Phytomedicine. 2016 Dec 1;23(13):1629–1637. doi: 10.1016/j.phymed.2016.10.007. PubMed PMID: 27823627. Epub 2016/11/09. eng. [DOI] [PubMed] [Google Scholar]
- 98.Grochowski D.M., Locatelli M., Granica S., Cacciagrano F., Tomczyk M. A review on the dietary flavonoid tiliroside. Compr. Rev. Food Sci. Food Saf. $V. 2018;17(5):1395–1421. doi: 10.1111/1541-4337.12389. [DOI] [PubMed] [Google Scholar]
- 99.Velagapudi R., El-Bakoush A., Olajide O.A. Activation of Nrf2 pathway contributes to neuroprotection by the dietary flavonoid tiliroside. Mol. Neurobiol. 2018 Oct;55(10):8103–8123. doi: 10.1007/s12035-018-0975-2. PubMed PMID: 29508282. PMCID: PMC6132780. Epub 2018/03/07. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Yang X., Jiang H., Shi Y. Upregulation of heme oxygenase-1 expression by curcumin conferring protection from hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblasts. Cell Biosci. 2017;7:20. doi: 10.1186/s13578-017-0146-6. PubMed PMID: 28439402. PMCID: PMC5401460. Epub 2017/04/26. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Linker R.A., Lee D.H., Ryan S., van Dam A.M., Conrad R., Bista P. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011 Mar;134(Pt 3):678–692. doi: 10.1093/brain/awq386. PubMed PMID: 21354971. Epub 2011/03/01. eng. [DOI] [PubMed] [Google Scholar]
- 102.Ikram M., Muhammad T., Rehman S.U., Khan A., Jo M.G., Ali T. Hesperetin confers neuroprotection by regulating Nrf2/TLR4/NF-κB signaling in an Aβ mouse model. Mol. Neurobiol. 2019 September 01;56(9):6293–6309. doi: 10.1007/s12035-019-1512-7. [DOI] [PubMed] [Google Scholar]
- 103.Zheng Y., Zhu G., He J., Wang G., Li D., Zhang F. Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation. Int. Immunopharm. 2019 Aug;73:304–311. doi: 10.1016/j.intimp.2019.05.033. PubMed PMID: 31128530. Epub 2019/05/28. eng. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No data was used for the research described in the article.



